SIGNATURE ESTATE & INVESTMENT ADVISORS LLC
Position in AXSM — Axsome Therapeutics, Inc.
CIK 1079935
LOS ANGELES, CA
Position in AXSM
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$309,644
-$24,952 QoQ
Shares Held
1,832
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
13 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SIGNATURE ESTATE & INVESTMENT ADVISORS LLC holds $505,847 across 4 Biotechnology names. AXSM ranks #1 (61.2% of the industry book) .
All Filings in AXSM
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $309,644 | 1,832 | Shares | Defined | 2026-04-15 | |
| 2025-12-31 | $334,596 | 1,832 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $222,496 | 1,832 | Shares | Defined | 2025-11-05 | |
| 2025-03-31 | $213,666 | 1,832 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $222,693 | 2,632 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $236,537 | 2,632 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $211,876 | 2,632 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $210,033 | 2,632 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $241,714 | 3,037 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $212,255 | 3,037 | Shares | Defined | 2023-10-26 | |
| 2022-12-31 | $203,006 | 2,632 | Shares | Defined | 2023-01-11 | |
| 2020-12-31 | $214,429 | 2,632 | Shares | Defined | 2021-01-13 | |
| 2020-06-30 | $216,560 | 2,632 | Shares | Defined | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||